指南与共识肝病

欧洲肝病学会慢加急性肝衰竭临床实践指南

EASL Clinical Practice Guidelines on acute-on-chronic liver failure.
指南 / 共识 · J Hepatol · 2023-06-24

该指南由欧洲肝病学会制定,针对慢加急性肝衰竭(ACLF)的识别、分诊(ICU与否)、诱因处理、器官支持、ICU无益标准及肝移植指征提供推荐,采用牛津循证医学中心系统分级为强或弱推荐。

要点

  • ACLF是急性失代偿肝硬化伴器官衰竭和高短期死亡风险的严重形式。
  • ACLF由临床明显或不明显的诱因触发过度全身炎症反应所致。
  • 部分ACLF患者可能受益于肝移植,需紧急稳定并评估移植。

核心结论

  • ACLF是急性失代偿肝硬化伴器官衰竭和高短期死亡风险的严重形式。
  • 部分ACLF患者可能受益于肝移植,应紧急稳定并评估移植。

研究设计与样本

  • 欧洲肝病学会基于相关文献深入综述制定临床实践指南,推荐按牛津循证医学中心系统分级为强或弱推荐。

主要发现

  • ACLF由临床明显或不明显的诱因触发过度全身炎症反应所致。
  • 重要研究提示ACLF患者可能受益于肝移植。

关键数值与推荐

  • 推荐帮助临床医生识别ACLF、决定ICU分诊、识别和管理急性诱因、识别需支持或替代的器官系统、定义ICU无益标准及识别肝移植潜在指征。
  • 推荐按牛津循证医学中心系统分级为强或弱推荐。

临床怎么用

  • 对ACLF患者应紧急稳定以评估肝移植,给予已识别诱因的适当治疗及全面综合管理,包括ICU器官支持。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute-on-chronic liver failure (ACLF), which was described relatively recently (2013), is a severe form of acutely decompensated cirrhosis characterised by the existence of organ system failure(s) and a high risk of short-term mortality. ACLF is caused by an excessive systemic inflammatory response triggered by precipitants that are clinically apparent (e.g., proven microbial infection with sepsis, severe alcohol-related hepatitis) or not. Since the description of ACLF, some important studies have suggested that patients with ACLF may benefit from liver transplantation and because of this, should be urgently stabilised for transplantation by receiving appropriate treatment of identified precipitants, and full general management, including support of organ systems in the intensive care unit (ICU). The objective of the present Clinical Practice Guidelines is to provide recommendations to help clinicians recognise ACLF, make triage decisions (ICU vs. no ICU), identify and manage acute precipitants, identify organ systems that require support or replacement, define potential criteria for futility of intensive care, and identify potential indications for liver transplantation. Based on an in-depth review of the relevant literature, we provide recommendations to navigate clinical dilemmas followed by supporting text. The recommendations are graded according to the Oxford Centre for Evidence-Based Medicine system and categorised as 'weak' or 'strong'. We aim to provide the best available evidence to aid the clinical decision-making process in the management of patients with ACLF.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. EASL Clinical Practice Guidelines on acute-on-chronic liver failure. J Hepatol. 2023. PMID: 37364789. doi:10.1016/j.jhep.2023.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。